Archeus Technologies

Executive Summary

Archeus Technologies is a privately held radiopharmaceuticals company headquartered in San Diego, California, founded in 2016. The company is developing targeted, patient-specific therapies for some of the most difficult-to-treat cancers, with a stated ambition to achieve truly curative responses rather than merely extending life. Archeus leverages unique cancer-targeting agents and a novel treatment approach aimed at historically terminal diseases. Currently in Phase 1 clinical development, the company is advancing its lead candidate through early-stage trials, focusing on solid tumors with high unmet medical need. The platform's differentiation lies in its precision targeting and potential for durable remissions, which could address significant gaps in current oncology treatment paradigms.

Upcoming Catalysts (preview)

• H1 2027Initial Phase 1 Clinical Data Readout50% success
• 2027Strategic Partnership or Licensing Deal with Major Pharma40% success
• H2 2026Series B Financing Round70% success